Editorial Board About Us

Urge incontinence

All articles from this key word are listed below.

Volume 3, Supplement 1 Supplement

The Prevalence of Urinary Incontinence

Urge incontinence Incontinence Epidemiology Etiology Prevalence Incidence

Volume 3, Supplement 1 Supplement

Recent Clinical Studies of New Pharmacologic Agents and Their Efficacy in the Treatment of Incontine

Rodney A Appell

Overactive bladder Urge incontinence Oxybutynin Tolterodine Anticholinergic

Volume 3, Supplement 1 Supplement

Potential Targets in the Treatment of Urinary Incontinence

Overactive bladder Urge incontinence Nerve growth factor Receptor blockade Neuroplasticity Neurotransmitter

Volume 12, Number 1 Review Articles

A Comparative Review of Oxybutynin Chloride Formulations: Pharmacokinetics and Therapeutic Efficacy in Overactive Bladder

Treatment Update

Michael J Kennelly

Antimuscarinic agents remain the mainstay of treatment of overactive bladder. However, the utility of some of these agents is limited due to tolerability concerns, multiple daily dosage regimens, lack of formulary coverage, and high cost. This can lead to problems with long-term compliance and may preclude optimal management. Oxybutynin has been the most widely prescribed antimuscarinic agent for more than 30 years. To meet the needs of tolerability and compliance, oxybutynin has evolved from an immediate-release pill to a once-daily oral dose and is now available as a topical gel. This review compares the various oxybutynin formulations in terms of pharmacokinetics, efficacy, and tolerability issues.[Rev Urol. 2010;12(1):12-19 doi: 10.3909/riu0484]

Overactive bladder Urge incontinence Oxybutynin N-desethyloxybutynin

Volume 17, Number 2 Review Articles

Diagnosis, Evaluation, and Treatment of Mixed Urinary Incontinence in Women

Diagnosis and Treatment Update

Steven A Kaplan Leanna Laor Claire Dunphy Richard Lee Bilal Chughtai Alexis E Te

Mixed urinary incontinence (MUI) is a common clinical problem in the community and hospital setting. The broad definition of the term makes it difficult to diagnose, as well as determine effective treatment strategies. There are no current guidelines recommended for physicians. The estimated prevalence of this condition is approximately 30% in all women with incontinence. It has also been suggested that patients with MUI report more bothersome symptoms than either stress or urge incontinence; approximately 32% of 40- to 64-year-olds with MUI report symptoms of depression. The authors examine the diagnosis, evaluation, and treatment of patients with MUI. [Rev Urol. 2015;17(2):78-83 doi: 10.3909/riu0653] © 2015 MedReviews®, LLC

Mixed urinary incontinence Detrusor overactivity Stress incontinence Urge incontinence Urodynamic stress incontinence Pelvic organ prolapse Transvaginal tape